Key facts
- It has raised $8.0M.
- Notable investors include AIX Ventures, iSelect Fund, New Era Capital Partners, CoLAB Accelerator, Newland Syndicate — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Alphabiome
- ·The full record, as it builds
Funding rounds
No funding rounds for Alphabiome are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Alphabiome
Developer of an agricultural technology platform designed to address the environmental issues associated with bovine methane production. The company's platform partners with farmers and other stakeholders in the meat and dairy industry to globally expand the deployment of our novel microbiome analytics technology individually customized for each herd and can predict the impact of specific feedstock on methane production and match herds of cattle with feedstock designed to reduce that production based on particular microbiome considerations, enabling dairy and cattle farmers produce quality food in sustainable ways by reducing their methane emissions and monetizing their carbon credits.
- Sector
- Materials and Resources
- HQ
- Ramat Yishai, Israel
- Founded
- 2022
- Employees
- 17
- Website
- alphabiome.ai/
- Ownership
- Privately Held (backing)
Alphabiome doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Alphabiome shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Alphabiome in its N-PORT filings yet. We sweep new filings monthly.